A NOVEL FLAVONOL DERIVATIVE FOR INHIBITING THE ACTIVIT OF HCV RNA-DEPENDENT RNA POLYMERASE

PURPOSE: A novel flavonol derivative is provided to suppress hepatitis C virus RNA nucleic acid polymerase(HCV RdRp) and to use as a therapeutic agent for hepatitis C. CONSTITUTION: A novel flavonol derivative compound or pharmaceutically acceptable salt has an effect of preventing or treating hepat...

Full description

Saved in:
Bibliographic Details
Main Authors KIM, JIN YOUNG, KIM, DONG EUN, CHONG, YOU HOON, KIM, KI SUN
Format Patent
LanguageEnglish
Korean
Published 08.07.2010
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:PURPOSE: A novel flavonol derivative is provided to suppress hepatitis C virus RNA nucleic acid polymerase(HCV RdRp) and to use as a therapeutic agent for hepatitis C. CONSTITUTION: A novel flavonol derivative compound or pharmaceutically acceptable salt has an effect of preventing or treating hepatitis C virus infection. A pharmaceutical composition contains flavonol derivative compound of pharmaceutically acceptable salt and carrier. The flavonol derivative domopund, pharmaceutically acceptable salt thereof, solvent, or hydrate is administered in 0.1 mg-1000 mg/day.
Bibliography:Application Number: KR20080137375